An agreement has been signed with Novavax to purchase corona vaccines.
NovoWax’s vaccine is based on protein-based technology and allows Israel to have technological diversity and a broader response against the corona virus.
The vaccine, which has been found to be effective in several studies against different variants, is expected to be given in two doses. >>>
An agreement has been signed with Novavax to purchase corona vaccines.
NovoWax’s vaccine is based on protein-based technology and allows Israel to have technological diversity and a broader response against the corona virus.
The vaccine, which has been found to be effective in several studies against different variants, is expected to be given in two doses. >>>– Ministry of Health (@IsraelMOH) January 28, 2022
Clarification: The content of the article is published automatically From the Twitter page By Ministry of Health Content and media are the sole responsibility of the advertiser.
